Measles, mumps, rubella prevention: how can we do better?
- PMID: 34096442
- DOI: 10.1080/14760584.2021.1927722
Measles, mumps, rubella prevention: how can we do better?
Abstract
Introduction: Measles, mumps, and rubella incidence decreased drastically following vaccination programs' implementation. However, measles and mumps' resurgence was recently reported, outbreaks still occur, and challenges remain to control these diseases.
Areas covered: This qualitative narrative review provides an objective appraisal of the literature regarding current challenges in controlling measles, mumps, rubella infections, and interventions to address them.
Expert opinion: While vaccines against measles, mumps, and rubella (including trivalent vaccines) are widely used and effective, challenges to control these diseases are mainly related to insufficient immunization coverage and changing vaccination needs owing to new global environment (e.g. traveling, migration, population density). By understanding disease transmission peculiarities by setting, initiatives are needed to optimize vaccination policies and increase vaccination coverage, which was further negatively impacted by COVID-19 pandemic. Also, awareness of the potential severity of infections and the role of vaccines should increase. Reminder systems, vaccination of disadvantaged, high-risk and difficult-to-reach populations, accessibility of vaccination, healthcare infrastructure, and vaccination services management should improve. Outbreak preparedness should be strengthened, including implementation of high-quality surveillance systems to monitor epidemiology. While the main focus should be on these public health initiatives to increase vaccination coverage, slightly more benefits could come from evolution of current vaccines.
Keywords: Coverage; MMR uptake; MMR vaccine; elimination; measles; mumps; prevention; protection; rubella; vaccine effectiveness.
Plain language summary
PLAIN LANGUAGE SUMMARYWhat is the context?Measles, mumps, and rubella are highly contagious diseases associated with significant medical and societal burden. Effective vaccines against these diseases are available, and the implementation of vaccination programs drastically reduced disease incidence globally. However, reports of measles and mumps outbreaks in the last few years highlight remaining challenges to eliminate these diseases.What does the review highlight?We conducted a literature review to identify challenges associated with controlling measles, mumps, and rubella infections, and interventions needed to address them. We identified 11 challenges mainly related to low immunization coverage and vaccine characteristics. Societal challenges could be addressed by increasing awareness of disease severity and vaccines impact, targeting high-risk, unvaccinated, and under-vaccinated populations, improving vaccination access, setting up clear outbreak preparedness plans, and implementing country-specific vaccination policies. System weaknesses could be addressed through improving vaccination services and health infrastructure, implementing high-quality surveillance, patient invite, and reminder systems, ensuring vaccine implementation and long-term supply. Interventions related to vaccine characteristic challenges could include adaptation of vaccination schedules (shorter interval between doses, administration of a third dose) and development of vaccines against emerging strains.What is the take-home message?Policymakers should support the following strategies to increase vaccination coverage and reach elimination of measles, mumps, and rubella: strengthening health systems and vaccination access; raising awareness of disease severity and vaccination impact; limiting disease propagation owing to global changing environment and population dynamics (traveling, migration); improving surveillance systems to rapidly address the immunity gaps against disease resurgence.
Similar articles
-
Characterisation of measles after the introduction of the combined measles-mumps-rubella (MMR) vaccine in 2004 with focus on the laboratory data, 2016 to 2019 outbreak, Romania.Euro Surveill. 2019 Jul;24(29):1900041. doi: 10.2807/1560-7917.ES.2019.24.29.1900041. Euro Surveill. 2019. PMID: 31339098 Free PMC article.
-
Successes and challenges for preventing measles, mumps and rubella by vaccination.Curr Opin Virol. 2019 Feb;34:110-116. doi: 10.1016/j.coviro.2019.01.002. Epub 2019 Mar 7. Curr Opin Virol. 2019. PMID: 30852425 Review.
-
Prevention of measles, rubella, congenital rubella syndrome, and mumps, 2013: summary recommendations of the Advisory Committee on Immunization Practices (ACIP).MMWR Recomm Rep. 2013 Jun 14;62(RR-04):1-34. MMWR Recomm Rep. 2013. PMID: 23760231
-
MMR vaccination and disease elimination: the Finnish experience.Expert Rev Vaccines. 2010 Sep;9(9):1045-53. doi: 10.1586/erv.10.99. Expert Rev Vaccines. 2010. PMID: 20822347 Review.
-
Why do parents hesitate to vaccinate their children against measles, mumps and rubella?Acta Paediatr. 2004 Sep;93(9):1232-7. Acta Paediatr. 2004. PMID: 15384890
Cited by
-
Determinants of second-dose measles vaccination dropout in Ethiopia: A community-based matched case-control study.Heliyon. 2024 May 4;10(9):e30764. doi: 10.1016/j.heliyon.2024.e30764. eCollection 2024 May 15. Heliyon. 2024. PMID: 38756559 Free PMC article.
-
Case Ascertainment of Measles during a Large Outbreak-Laboratory Compared to Epidemiological Confirmation.Diagnostics (Basel). 2024 Apr 30;14(9):943. doi: 10.3390/diagnostics14090943. Diagnostics (Basel). 2024. PMID: 38732357 Free PMC article.
-
A review of safety and immunogenicity of a novel measles, mumps, rubella (MMR) vaccine.Hum Vaccin Immunother. 2024 Dec 31;20(1):2302685. doi: 10.1080/21645515.2024.2302685. Epub 2024 Jan 18. Hum Vaccin Immunother. 2024. PMID: 38236022 Free PMC article. Review.
-
Rubella Vaccine Uptake among Women of Childbearing Age in Healthcare Settings.Healthcare (Basel). 2023 Nov 19;11(22):2992. doi: 10.3390/healthcare11222992. Healthcare (Basel). 2023. PMID: 37998484 Free PMC article.
-
Health system barriers to timely routine measles vaccinations in rural southwest China: a qualitative study on the perspectives of township vaccination professionals and village doctors.BMJ Open. 2023 Nov 22;13(11):e072990. doi: 10.1136/bmjopen-2023-072990. BMJ Open. 2023. PMID: 37993157 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical